Author Archive: Jeremy Parkinson
ECRI Weekly Leading Index Update: WLI Down From Last Week
Friday’s release of the publicly available data from ECRI puts its Weekly Leading Index (WLI) at 149.3, down 1.0 from the previous week. Year-over-year the four-week moving average of the indicator is now at 3.29%, down from 3.66% last week. The WLI Growth indicator is now at 5.7, down from the previous week. “Up is […]
WTI/RBOB Rise After Smaller Than Expected Crude Build
Anxiety over Rexit and growing concerns that global demand might not absorb swelling US supplies sent WTI/RBOB notably lower today but prices rebounded modestly after API showed notable product draws and smaller than expected crude build. “The EIA report yesterday about the expected increase in shale output next month certainly weighed on things,” John Kilduff, founding partner […]
And You Thought Volatility Was Dead?
Video length: 00:10:20 Stocks sink lower as volatility returns into the market. In this crucial video update we look at several trading opportunities. Watch the video now to get the trades…
Market Talk – Tuesday, March 13
A pretty mixed bag for Asia today with most core indices playing around unchanged for much of the day. The late weakness in the DOW obviously didn’t help confidence but then futures are bouncing back in Asian trading. The talk surrounding US tariffs still add a dampener on the Asian producers and that may be […]
Welfare Versus GDP: What Makes People Better Off
from the International Monetary Fund — this post authored by Geoffrey Bannister and Alexandros Mourmouras For years, economists have worked to develop a way of measuring general well-being and comparing it across countries. The main metric has been differences in income or gross domestic product per person. But economists have long known that GDP is an imperfect measure […]
Weekly Unemployment Claims: Up 21K, Worse Than Forecast
Here is the opening statement from the Department of Labor: In the week ending March 3, the advance figure for seasonally adjusted initial claims was 231,000, an increase of 21,000 from the previous week’s unrevised level of 210,000. The 4-week moving average was 222,500, an increase of 2,000 from the previous week’s unrevised average of […]
My Leitner-Esque Moment
They’re back. I thought they had all given up, but like an old college buddy who’s going through a bad divorce and just needs a place to crash for a ‘few days,’ the corporate credit skeptics are a tough lot to shake. This crew is a left-over remnant of the 2008 Great Financial Crisis. After […]
3 Biotech Stocks With Rising Earnings Estimates Post Q4
The Q4 earnings season for the pharma/biotech sector was scattered with a few small biotech companies yet to report. The releases so far provide us with a clear picture of the sector’s performance. Overall, the sector performed reasonably well. Among the biotech/pharma bigwigs, Gilead (GILD – Free Report) , Celgene (CELG – Free Report) and Vertex (VRTX – Free Report) beat […]
Stocks Fall After Revenue Beats Expectations
Beat Expectations, Stock Falls Anyway In the Q2 2017 earnings season, the market was acting weirdly. Stocks were falling when firms were beating sales expectation. My guess was that stocks priced in great results, so investors weren’t enamored after results were beat. In the Q1 2018 earnings season we’re seeing the same phenomena occur. As […]
